Most people on GLP-1 drugs can safely fast for Yom Kippur or other religious observances, but they may need to plan ahead, take certain precautions or be ready to call it quits if they feel ill.
Articles on GLP-1 drugs
Displaying all articles
Drug companies are using women of colour and First Nations celebrities in weight-loss campaigns. Not everyone’s happy.
Several studies suggest GLP-1 drugs may lower cancer risk. But that benefit may be due to the patients themselves: those who are healthier, wealthier and with better access to care.
GLP-1 drugs show promise for more than weight loss. They also cut substance abuse and are changing how we think about the brain’s reward system.
As celebrity shrinking dominates the red carpet, the Met’s Costume Art exhibition bucks the trend with body shapes that signal acceptance and inclusion.
The thriving market in online, counterfeit GLP-1 drugs that do not meet FDA criteria poses serious risks to consumers.
GLP-1 drugs are the first medication to show promise for treating addiction to a wide range of substances.
Due to the body’s natural tendency to restore its former weight, many people regain their lost weight when they stop using GLP-1 drugs.
Additional policy changes can help change key factors that drive obesity.
Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health conditions.
Top contributors
-
Clinical Epidemiologist, Washington University in St. Louis
-
Associate Professor of Medicine, University of Florida
-
Professor of Social and Behavioral Sciences, Temple University
-
PhD Candidate in Pharmacy Administration, University of Mississippi
-
Associate Professor of Pharmacy Administration, University of Mississippi
-
Lecturer in History of Art and Liberal Arts, University of Bristol
-
Senior Lecturer, University of Otago
-
Associate Professor, Deakin Centre for Global Preventive Health and Nutrition, Deakin University
-
Senior Research Fellow, Poche Centre for Indigenous Health, University of Sydney
-
Senior Research Fellow, School of Health and Social Development, Deakin University
-
Associate Clinical Professor of Medicine and Surgery, University of Illinois Chicago